EUVIMEDEUVIMED entdecken
Crossref

Precisely Staging Diabetic Nephropathy by a Gold-Based Artificial Filtration Biomarker through Computed Tomography and Blood Testing of the Glomerular Filtration Rate

Xunzhi Wu, Huixu Lu, Yexi Peng, Mingze Xu, Yuming Qi, Yuhan Yi, Yuanqing Song iD, Xiaoxian Wang, Yazhe Liang, Tiankai Chen iD, Xingya Jiang iD, Bujie Du iD

ACS Nano · 2026

DOI: 10.1021/acsnano.5c17310 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Xunzhi Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Medical Research on Innovation and Translation, Institute of Clinical Medicine, the Second Affiliated Hospital, School of Medicine, South …. Hauptthemen laut MEDLINE: Gold, Tomography, X-Ray Computed, Diabetic Nephropathies, Glomerular Filtration Rate. Die Arbeit nennt 56 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Guangzhou First People's Hospital, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoldTomography, X-Ray ComputedDiabetic NephropathiesGlomerular Filtration RateAnimalsBiomarkersMiceMaleMetal NanoparticlesHumans

Stichwörter der Autor:innen

computed tomographydiabetic nephropathyglomerular filtration ratekidney disease stagingrenal-clearable gold nanoparticles

Substanzen

GoldBiomarkers

Autor:innen und Institutionen

  • Center for Medical Research on Innovation and Translation, Institute of Clinical Medicine, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, P. R. China.
  • School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 511442, P. R. China.
  • Guangdong Basic Research Center of Excellence for Aggregate Science, School of Science and Engineering, The Chinese University of Hong Kong, Shenzhen, Guangdong 518172, China.
  • National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou 510006, P. R. China.
  • Guangdong Provincial Key Laboratory of Biomedical Engineering, South China University of Technology, Guangzhou 510006, PR China.
  • Key Laboratory of Biomedical Materials and Engineering of the Ministry of Education, South China University of Technology, Guangzhou 510006, P. R. China.

ORCID-Profile: Yuanqing Song, Tiankai Chen, Xingya Jiang, Bujie Du

Förderung

  • National Key Research and Development Program of China
  • Guangzhou First People's Hospital
  • National Natural Science Foundation of China
  • GJYC program of Guangzhou

Zitieren

APA

Wu, X., Lu, H., Peng, Y., Xu, M., Qi, Y., Yi, Y., Song, Y., Wang, X., Liang, Y., Chen, T., Jiang, X., & Du, B. (2026). Precisely Staging Diabetic Nephropathy by a Gold-Based Artificial Filtration Biomarker through Computed Tomography and Blood Testing of the Glomerular Filtration Rate. ACS Nano. https://doi.org/10.1021/acsnano.5c17310

Vancouver

Wu X, Lu H, Peng Y, Xu M, Qi Y, Yi Y, et al. Precisely Staging Diabetic Nephropathy by a Gold-Based Artificial Filtration Biomarker through Computed Tomography and Blood Testing of the Glomerular Filtration Rate. ACS Nano. 2026. doi:10.1021/acsnano.5c17310

BibTeX
@article{Wu2026,
  author = {Wu, Xunzhi and Lu, Huixu and Peng, Yexi and Xu, Mingze and Qi, Yuming and Yi, Yuhan and Song, Yuanqing and Wang, Xiaoxian and Liang, Yazhe and Chen, Tiankai and Jiang, Xingya and Du, Bujie},
  title = {Precisely Staging Diabetic Nephropathy by a Gold-Based Artificial Filtration Biomarker through Computed Tomography and Blood Testing of the Glomerular Filtration Rate},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.5c17310}
}
Kostenlos starten →